Squarepoint Ops LLC Cyclerion Therapeutics, Inc. Transaction History

Squarepoint Ops LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 15, 2020	SELL	$2.46 - $5.84 $336,818 - $799,601	-136,918 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$1.8 - $13.43 $86,166 - $642,894	47,870 Added 53.76%	136,918 $372,000
Q3 2019 Nov 14, 2019	BUY	$8.12 - $14.54 $304,443 - $545,148	37,493 Added 72.72%	89,048 $1.08 Million
Q2 2019 Aug 14, 2019	BUY	$9.6 - $22.85 $494,928 - $1.18 Million	51,555 New	51,555 $590,000

293K

Ticker CYCN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,479,800
Market Cap $137M
Description
Cyclerion Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovering, development, and commercialization of medicines for serious central nervous system (CNS) diseases. Its lead product candidate is CY6463, a CNS-penetrant, soluble guanylate cyclase (sGC) stimulator that is in Phase IIa trials for the treatment of...

Get notified when there are updates to the investment portfolio of Squarepoint Ops LLC, based on Form 13F filings with the SEC.

Stay updated on Squarepoint Ops LLC with notifications on news.